These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 18234116)
1. Crystal structures of a purple acid phosphatase, representing different steps of this enzyme's catalytic cycle. Schenk G; Elliott TW; Leung E; Carrington LE; Mitić N; Gahan LR; Guddat LW BMC Struct Biol; 2008 Jan; 8():6. PubMed ID: 18234116 [TBL] [Abstract][Full Text] [Related]
2. Mechanism of Fe(III)-Zn(II) purple acid phosphatase based on crystal structures. Klabunde T; Sträter N; Fröhlich R; Witzel H; Krebs B J Mol Biol; 1996 Jun; 259(4):737-48. PubMed ID: 8683579 [TBL] [Abstract][Full Text] [Related]
3. Phosphate forms an unusual tripodal complex with the Fe-Mn center of sweet potato purple acid phosphatase. Schenk G; Gahan LR; Carrington LE; Mitic N; Valizadeh M; Hamilton SE; de Jersey J; Guddat LW Proc Natl Acad Sci U S A; 2005 Jan; 102(2):273-8. PubMed ID: 15625111 [TBL] [Abstract][Full Text] [Related]
4. Crystal structure of a purple acid phosphatase containing a dinuclear Fe(III)-Zn(II) active site. Sträter N; Klabunde T; Tucker P; Witzel H; Krebs B Science; 1995 Jun; 268(5216):1489-92. PubMed ID: 7770774 [TBL] [Abstract][Full Text] [Related]
5. Identification of purple acid phosphatase inhibitors by fragment-based screening: promising new leads for osteoporosis therapeutics. Feder D; Hussein WM; Clayton DJ; Kan MW; Schenk G; McGeary RP; Guddat LW Chem Biol Drug Des; 2012 Nov; 80(5):665-74. PubMed ID: 22943065 [TBL] [Abstract][Full Text] [Related]
6. The reaction mechanism of the Ga(III)Zn(II) derivative of uteroferrin and corresponding biomimetics. Smith SJ; Casellato A; Hadler KS; Mitić N; Riley MJ; Bortoluzzi AJ; Szpoganicz B; Schenk G; Neves A; Gahan LR J Biol Inorg Chem; 2007 Nov; 12(8):1207-20. PubMed ID: 17701232 [TBL] [Abstract][Full Text] [Related]
7. The Binding Mode of an ADP Analogue to a Metallohydrolase Mimics the Likely Transition State. Feder D; Gahan LR; McGeary RP; Guddat LW; Schenk G Chembiochem; 2019 Jun; 20(12):1536-1540. PubMed ID: 30719821 [TBL] [Abstract][Full Text] [Related]
8. Fluoride inhibition of bovine spleen purple acid phosphatase: characterization of a ternary enzyme-phosphate-fluoride complex as a model for the active enzyme-substrate-hydroxide complex. Pinkse MW; Merkx M; Averill BA Biochemistry; 1999 Aug; 38(31):9926-36. PubMed ID: 10433699 [TBL] [Abstract][Full Text] [Related]
9. Crystal structure of mammalian purple acid phosphatase. Guddat LW; McAlpine AS; Hume D; Hamilton S; de Jersey J; Martin JL Structure; 1999 Jul; 7(7):757-67. PubMed ID: 10425678 [TBL] [Abstract][Full Text] [Related]
10. Identification and molecular modeling of a novel, plant-like, human purple acid phosphatase. Flanagan JU; Cassady AI; Schenk G; Guddat LW; Hume DA Gene; 2006 Aug; 377():12-20. PubMed ID: 16793224 [TBL] [Abstract][Full Text] [Related]
11. Probing the role of the divalent metal ion in uteroferrin using metal ion replacement and a comparison to isostructural biomimetics. Schenk G; Peralta RA; Batista SC; Bortoluzzi AJ; Szpoganicz B; Dick AK; Herrald P; Hanson GR; Szilagyi RK; Riley MJ; Gahan LR; Neves A J Biol Inorg Chem; 2008 Jan; 13(1):139-55. PubMed ID: 17938975 [TBL] [Abstract][Full Text] [Related]
12. Comparative theoretical studies of the phosphomonoester hydrolysis mechanism by purple acid phosphatases. Retegan M; Milet A; Jamet H J Phys Chem A; 2010 Jul; 114(26):7110-6. PubMed ID: 20550096 [TBL] [Abstract][Full Text] [Related]
13. Binuclear metal centers in plant purple acid phosphatases: Fe-Mn in sweet potato and Fe-Zn in soybean. Schenk G; Ge Y; Carrington LE; Wynne CJ; Searle IR; Carroll BJ; Hamilton S; de Jersey J Arch Biochem Biophys; 1999 Oct; 370(2):183-9. PubMed ID: 10510276 [TBL] [Abstract][Full Text] [Related]
14. Electronic structure and spectro-structural correlations of Fe(III)Zn(II) biomimetics for purple acid phosphatases: relevance to DNA cleavage and cytotoxic activity. Peralta RA; Bortoluzzi AJ; de Souza B; Jovito R; Xavier FR; Couto RA; Casellato A; Nome F; Dick A; Gahan LR; Schenk G; Hanson GR; de Paula FC; Pereira-Maia EC; de P Machado S; Severino PC; Pich C; Bortolotto T; Terenzi H; Castellano EE; Neves A; Riley MJ Inorg Chem; 2010 Dec; 49(24):11421-38. PubMed ID: 21080710 [TBL] [Abstract][Full Text] [Related]
15. Purple acid phosphatase inhibitors as leads for osteoporosis chemotherapeutics. Hussein WM; Feder D; Schenk G; Guddat LW; McGeary RP Eur J Med Chem; 2018 Sep; 157():462-479. PubMed ID: 30107365 [TBL] [Abstract][Full Text] [Related]
16. Phosphotyrosyl peptides and analogues as substrates and inhibitors of purple acid phosphatases. Valizadeh M; Schenk G; Nash K; Oddie GW; Guddat LW; Hume DA; de Jersey J; Burke TR; Hamilton S Arch Biochem Biophys; 2004 Apr; 424(2):154-62. PubMed ID: 15047187 [TBL] [Abstract][Full Text] [Related]
17. Three-dimensional structure of a mammalian purple acid phosphatase at 2.2 A resolution with a mu-(hydr)oxo bridged di-iron center. Lindqvist Y; Johansson E; Kaija H; Vihko P; Schneider G J Mol Biol; 1999 Aug; 291(1):135-47. PubMed ID: 10438611 [TBL] [Abstract][Full Text] [Related]
18. Comparative studies of rat recombinant purple acid phosphatase and bone tartrate-resistant acid phosphatase. Ek-Rylander B; Barkhem T; Ljusberg J; Ohman L; Andersson KK; Andersson G Biochem J; 1997 Jan; 321 ( Pt 2)(Pt 2):305-11. PubMed ID: 9020859 [TBL] [Abstract][Full Text] [Related]
19. Structure-function relationships of purple acid phosphatase from red kidney beans based on heterologously expressed mutants. Truong NT; Naseri JI; Vogel A; Rompel A; Krebs B Arch Biochem Biophys; 2005 Aug; 440(1):38-45. PubMed ID: 16009331 [TBL] [Abstract][Full Text] [Related]